Biosurgery Market: Current Analysis and Forecast (2021-2027)

Biosurgery Market: Current Analysis and Forecast (2021-2027)

  • UnivDatos Market Insight
  • August 2021
  • Healthcare
  • 182 pages

Report Description

In various surgeries, biosurgery products are utilized to reduce intra- and post-operative problems. The inefficient use of standard wound closure materials, such as sutures and staples, is one of the leading causes of blood loss in surgical and trauma patients. The rising frequency of accidents around the world has resulted in an increase in the number of procedures requiring extensive operating hours. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed. As per an article published by National Library of Medicine, in 2019, uncontrolled hemorrhage is the leading cause of preventable death that occurs due to injury. Similarly, as per National Trauma Institute, after a traumatic injury, hemorrhage is responsible for over 35% of pre-hospital deaths and over 40% of deaths within the first 24 hours of the injury. The number of surgeries that involve long operating times is increasing. In such a scenario, there is a growing demand for effective blood loss management products.

Furthermore, advancements in surgeries and novel product launch to help surgeons perform surgeries efficiently are expected to further fuel the market.

Based on product, the global Biosurgery market is bifurcated into surgical sealants, hemostatic agents, adhesion barriers, soft tissue attachments, and bone graft attachments. Currently, bone graft attachments testing segment dominated the market and is expected to maintain its dominance during the forecast period. The largest share of the segment is attributed to the increasing use of bone graft substitute products in orthopedic and dental surgeries and significant benefits offered by bone graft substitute products over conventional autograft products.

Based on application the market is divided into general Surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, and others (reconstructive, urology, and gynecology surgeries). Orthopedic surgery dominated the market in 2020 owing to prevalence of bone diseases, and cases of road accidents. However, cardiovascular surgery is expected to grow at a fast pace during the forecast period owing to the prevalence of diabetes and heart disease.

Based on end-user the market is bifurcated into hospitals, clinics, and others. Currently hospitals segment dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Netherlands, Spain, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America constitutes a major market for Biosurgery owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include Johnson & Johnson (Ethicon), Medtronic Plc, Strykers, Baxter International Inc., C.R. Bard, Sanofi, Pfizer, B. Braun Melsungen AG, Integra Lifesciences Corporation, and Zimmer Biomet.

Global Biosurgery Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Biosurgery Market is expected to witness a boost on account of the increasing prevalence chronics disease and increasing road accidents.

In various surgeries, biosurgery products are utilized to reduce intra- and post-operative problems. The inefficient use of standard wound closure materials, such as sutures and staples, is one of the leading causes of blood loss in surgical and trauma patients. The rising frequency of accidents around the world has resulted in an increase in the number of procedures requiring extensive operating hours. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed. As per an article published by National Library of Medicine, in 2019, uncontrolled hemorrhage is the leading cause of preventable death that occurs due to injury. Similarly, as per National Trauma Institute, after a traumatic injury, hemorrhage is responsible for over 35% of pre-hospital deaths and over 40% of deaths within the first 24 hours of the injury. The number of surgeries that involve long operating times is increasing. In such a scenario, there is a growing demand for effective blood loss management products.

Furthermore, factors such as advancements in surgeries and novel product launch to help surgeons perform surgeries efficiently are expected to further fuel the market. For instance, as per Eurostats, in 2018, caesarian procedure was performed at least 1.16 million times in the EU. A total of 233 300 caesarean sections were performed in Germany, while 146,200 to 151,100 were performed in Poland, France, and Italy, also the high number of caesarean sections of about 685,500 were performed in Turkey (685, 500) in 2018. 

As per WHO report in 2018, every year approximately 1.3 million people of people die because of a road traffic crash. Moreover, between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability because of their injury. Moreover, falls are also one of the major public health problems. According to WHO, estimated 684,000 fatal falls occur each year, making it the second leading cause of unintentional injury death, after road traffic injuries, worldwide. With over 80% of fall-related fatalities occur in low- and middle-income countries, and with regions of the Western Pacific and South-East Asia accounting for 60% of these deaths. Globally, death rates are highest among adults over the age of 60 years. In many cases of these accidents, the death is due to extreme blood loss either during or post-surgery. Hence, the increase in road accident fatalities has increased the demand for biosurgery

Johnson & Johnson (Ethicon), Medtronic Plc, Strykers, Baxter International Inc., C.R. Bard, Sanofi, Pfizer, B. Braun Melsungen AG, Integra Lifesciences Corporation, and Zimmer Biomet are some of the prominent players operating in the global Biosurgery market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst product, bone graft attachments segment holds the major share”

Based on product, the global Biosurgery market is bifurcated into surgical sealants, hemostatic agents, adhesion barriers, soft tissue attachments, and bone graft attachments. The bone graft attachments segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the owing to the rising requirements for dental bone grafts and technological advancements. As per Minim Invasive Surg in 2018, that minimally invasive procedures are being adopted for the treatment of a varied range of bone disorders in the year. It also stated that about 400,000 spinal fusion cases were done in the U.S. annually. Such factors positively impact market growth.

“Amongst application, orthopedic surgery is anticipated to grow at the highest CAGR during the analyzed period”

Further based on application, the market is fragmented into general surgery, orthopedic surgery, cardiovascular surgery, neurological surgery, and others (reconstructive, urology, and gynecology surgeries). In 2020, orthopedic surgery accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the rising prevalence of bone disease. Each year an estimated 1.5 million individuals suffer a fracture due to bone disease. Moreover, the risk of a fracture increases with age and is greatest in women. Roughly 4 in 10 White women aged 50 or older in the United States experiences a hip, spine, or wrist fracture sometime in their lifetime. Furthermore, the lifetime risk of developing rheumatoid arthritis for U.S. adults is 3.6 % for women and 1.7 percent for men.

“Amongst end-user, hospitals segment is anticipated to grow at the highest CAGR during the analyzed period”

Based on end-user, the market is fragmented into hospitals, clinics, and others. In 2020, hospitals accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the increasing number of hospitals and infrastructural development especially in the developing countries along with rising surgical procedures performed in operating rooms of hospitals. For instance, as of 2018, the number of hospitals and ambulatory surgery centers in the United States is almost equal with 5,532 surgery centers and 5,534 hospitals, as per JLL stats.

“North America signifies one of the largest markets of Biosurgery Market”

For a better understanding of the market dynamics of the Biosurgery market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to the increase in healthcare expenditure has also been boosting the market for biosurgery in the region. Among OECD member countries, the United States had the highest percentage of gross domestic product spent on health care in 2018 - or latest year available. The U.S. spent nearly 17 percent of its GDP on health care services. Switzerland, France, and Germany followed the U.S. with distinctly smaller percentages. 

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Biosurgery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Companies Covered

  • Johnson & Johnson (Ethicon)
  • Medtronic Plc
  • Strykers
  • Baxter International Inc.
  • C.R. Bard
  • Sanofi
  • Pfizer
  • B. Braun Melsungen AG
  • Integra Lifesciences Corporation
  • Zimmer Biomet

Have query on this report?

Make an Enquiry

Table of Content

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Biosurgery Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Biosurgery Market
2.1.1 Main Objective of the Global Biosurgery Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER BIOSURGERY INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL BIOSURGERY MARKET REVENUE

8 MARKET INSIGHTS BY PRODUCT

8.1 Surgical Sealants
8.2 Hemostatic Agents
8.3 Adhesion Barriers
8.4 Soft Tissue Attachments
8.5 Bone Graft Attachments

9 MARKET INSIGHTS BY APPLICATION
9.1 General Surgery
9.2 Orthopedic Surgery
9.3 Cardiovascular surgery
9.4 Neurological Surgery
9.5 Others (Reconstructive, Urology, and Gynecology Surgeries)

10 MARKET INSIGHTS BY END-USER
10.1 Hospitals
10.2 Clinics
10.3 Others

11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA BIOSURGERY MARKET
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 EUROPE BIOSURGERY MARKET
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Spain
11.2.5 Italy
11.2.6 Rest of Europe
11.3 ASIA PACIFIC BIOSURGERY MARKET
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 Rest of Asia Pacific
11.4 REST OF THE WORLD BIOSURGERY MARKET

12 BIOSURGERY MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
15 VALUE CHAIN ANALYSIS

16 BIOSURGERY MARKET OPPORTUNITIES

17 BIOSURGERY MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter’s Five forces analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
18.2 Competitive Landscape
18.2.1 Company Shares, By Revenue

19 COMPANY PROFILED
19.1 Medtronic PLC
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Key Product/Services Offerings
19.1.4 Growth Strategy
19.1.5 SWOT Analysis
19.1.6 Key Financials
19.1.6.1 Revenue Split
19.1.6.2 Financial Overview of Medtronics plc
19.1.7 Recent Developments
19.1.7.1 Product Launch
19.1.7.2 Partnerships
19.1.7.3 Business Expansion and Investments
19.1.7.4 Merger and Acquisition
19.2 Johnson & Johnson (Ethicon)
19.3 Strykers
19.4 Baxter International Inc.
19.5 C.R. Bard
19.6 Sanofi
19.7 Pfizer
19.8 B. Braun Melsungen AG
19.9 Integra Lifesciences Corporation
19.10 Zimmer Biomet

20 DISCLAIMER

Success Stories

Our Clients